"Pop a Tylenol and take a brisk walk for protection against prostate cancer Thats what the findings of two new studies published this week suggest. In the first study httpcebp.aacrjournals.orgcontentearly.EPI.abstractsidefffccdacfe published Monday in the journal Cancer Epidemiology Biomarkers and Prevention scientists found that men who took a daily dose of acetaminophen Tylenol for five years had a  lower risk of developing prostate cancer compared with other men. Additionally daily acetaminophen was associated with a  reduced risk of developing an aggressive form of the disease. Men who took acetaminophen for less than five years saw no protective benefit. More on TIME.com Coffee Drinking Linked With Lower Risk of Fatal Prostate Cancer httphealthland.time.comcoffeedrinkinglinkedwithlowerriskoffatalprostatecancer Previous research has shown that taking aspirin or other nonsteroidal antiinflammatory drugs NSAIDs every day may help reduce prostate cancer risk. The authors theorize that the same may be true of acetaminophen while not an NSAID it does have antiinflammatory properties. For the study the researchers looked at data from  men who participated in the longitudinal Cancer Prevention Study II Nutrition Cohort answering questions about diet and drug use every two years starting in . During the followup there were  cases of prostate cancer  significantly fewer in the group who took acetaminophen daily for five years. The second study httpcancerres.aacrjournals.orgcontentearly.CAN.abstract published online Tuesday by Cancer Research involved  men who had already been diagnosed with earlystage prostate cancer. Researchers from the University of California San Francisco UCSF and Harvard School of Public Health followed the men from  to  and found that those who engaged in regular brisk walking after diagnosis were significantly less likely to see their disease progress. More on TIME.com Study Gay Men Are Twice as Likely to Have Cancer httphealthland.time.comstudygaymenaretwiceaslikelytohavecancer Men who walked briskly  at a pace of about  miles per hour or faster  at least three hours per week were  less likely to experience disease progression including elevated PSA levels secondary treatment bone metastasis or prostate cancerrelated death compared with men who walked less and more slowly. The important point was the intensity of the activity Erin Richman a postdoctoral fellow at UCSF said in a statement. The walking had to be brisk for men to experience a benefit. The researchers said the effect of brisk walking persisted independent of age diagnosis type of treatment and characteristics of disease. The patients average age at diagnosis was . The findings are in line with previous research suggesting that physical activity may help reduce the risk of diseaserelated death in certain cases of prostate cancer. More on TIME.com Using Toenails to Predict Risk of Lung Cancer httphealthland.time.comstudyusingtoenailclippingstopredictriskoflungcancer Why the association MedPage Today reports http Richman and colleagues noted that the brisk walks may reduce insulin resistance which decreases bioavailable insulinlike growth factor IGF and increases adiponectin levels which are all associated with decreased risk of advanced or fatal prostate cancer in vitro and in vivo. Another potential source of the associated reduction was reduced inflammation due to a lower circulation of interleukin high levels of which predicted a  increased risk of dying from prostate cancer among normalweight men the researchers wrote. Prostate cancer is the second leading cause of cancer death in men. According httpseer.cancer.govstatfactshtmlprost.html to the National Cancer Institute about  men died from prostate cancer in  and  new cases were diagnosed. More than . million men in the U.S. are living with prostate cancer."